Cargando…

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors

BACKGROUND: This study aims to explore the efficacy and safety of mirabegron in treating irritative symptoms induced by intravesical immunotherapy with Bacillus Calmette–Guerin (BCG) after transurethral resection of bladder tumors (TURBT). METHODS: A total of 160 patients subjected to TURBT was rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Kai, Wang, Di, Wu, Gang, Ma, Jian, Wang, Tianqi, Wu, Jitao, Wang, Jipeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559481/ https://www.ncbi.nlm.nih.gov/pubmed/34547193 http://dx.doi.org/10.1002/cam4.4278

Ejemplares similares

Analysis of the Factors Causing Bladder Irritation after Transurethral Resection of the Prostate
por: Kim, Tae Im, et al.
Publicado: (2010)

Study of mirabegron and solifenacin in the improvement of catheter-related bladder discomfort in patients undergoing transurethral resection: A case–control study
por: Fan, Bohan, et al.
Publicado: (2022)

Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2021)

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Complete retroperitoneal laparoscopic nephroureterectomy with bladder cuff excision for upper tract urothelial carcinoma without patient repositioning: a single-center experience
por: Wu, Gang, et al.
Publicado: (2020)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
por: Ibrahimi, Ahmed, et al.
Publicado: (2020)

Mirabegron in the Management of Overactive Bladder Syndrome
por: O’Kane, Miriam, et al.
Publicado: (2022)

Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
por: Sun, Jian-Xuan, et al.
Publicado: (2023)

Comparison of Pathological Outcome and Recurrence Rate between En Bloc Transurethral Resection of Bladder Tumor and Conventional Transurethral Resection: A Meta-Analysis
por: Wang, Chi-Wei, et al.
Publicado: (2023)

Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis
por: Sun, Kai, et al.
Publicado: (2020)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis
por: Wu, Yu-Peng, et al.
Publicado: (2016)

Utility of restage transurethral resection of bladder tumor
por: Manoharan, Vignesh, et al.
Publicado: (2018)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer
por: Ozer, Kutan, et al.
Publicado: (2015)

A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection
por: Zhang, Kai-Yan, et al.
Publicado: (2017)

Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
por: Luu, Doan Tien, et al.
Publicado: (2021)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Potential Carbon Savings with Day-case Compared to Inpatient Transurethral Resection of Bladder Tumour Surgery in England: A Retrospective Observational Study Using Administrative Data
por: Phull, Manraj, et al.
Publicado: (2023)

Usefulness of narrow-band imaging in transurethral resection of bladder tumor: Early experience from a tertiary center in India
por: Malik, Kanuj, et al.
Publicado: (2019)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy
por: Zhang, Dongxu, et al.
Publicado: (2020)

Obturator Nerve Block for Transurethral Resection of Bladder Tumors
por: Gavrilovska-Brzanov, Aleksandra, et al.
Publicado: (2023)

Case report: Bladder preserving after maximal transurethral resection of the bladder tumor combined with chemotherapy and immunotherapy in recurrent muscle-invasive bladder cancer patients: A report of two cases
por: Mao, Jiaquan, et al.
Publicado: (2022)

Transurethral Resection of Bladder Tumor: Novel Techniques in a New Era
por: Sun, Shengkun, et al.
Publicado: (2023)

Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
por: Yu, Ge, et al.
Publicado: (2023)

Patient utilization survey of mirabegron prescribed for overactive bladder
por: Rahkola-Soisalo, Päivi, et al.
Publicado: (2019)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

Bladder leiomyoma treated with transurethral resection of bladder tumor (TURBT): Case report
por: AlHalak, Rouzy, et al.
Publicado: (2022)

The reasons and countermeasures of Bladder Rupture caused by Transurethral Clot Evacuation
por: Liu, Kai-long, et al.
Publicado: (2021)

Rectovesical Fistula Related to Transurethral Resection of a Bladder Lesion
por: Topaktaş, Ramazan, et al.
Publicado: (2011)

Intraabdominal Compartment Syndrome Complicating Transurethral Resection of Bladder Tumor
por: Narain, Sachin, et al.
Publicado: (2012)

Holmium laser transurethral resection of bladder tumor: Our experience
por: D’souza, Nischith, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_84jgl5cp3qe2tnrmit7sj63ef0